Active site-directed inactivation of constitutively active mutants of rhodopsin.

@article{Govardhan1994ActiveSI,
  title={Active site-directed inactivation of constitutively active mutants of rhodopsin.},
  author={Chandrika P. Govardhan and Daniel D. Oprian},
  journal={The Journal of biological chemistry},
  year={1994},
  volume={269 9},
  pages={
          6524-7
        }
}

Figures from this paper

Synthesis and characterization of a novel retinylamine analog inhibitor of constitutively active rhodopsin mutants found in patients with autosomal dominant retinitis pigmentosa.
  • T. Yang, B. Snider, D. Oprian
  • Biology, Chemistry
    Proceedings of the National Academy of Sciences of the United States of America
  • 1997
TLDR
The 11-cis C19 retinylamine analog 1 inhibits constitutive activation of transducin by these mutants and their constitutive phosphorylation by rhodopsin kinase, and it does so in the presence of continuous illumination from room lights.
Structural origins of constitutive activation in rhodopsin: Role of the K296/E113 salt bridge.
TLDR
The results provide structural evidence that the salt bridge is a key constraint maintaining the resting state of the receptor, and that the disruption of the salt Bridge is the cause, rather than a consequence, of the TM6 motion that occurs upon activation.
Mechanisms of Opsin Activation*
TLDR
P pH titrations suggested that an equilibrium exists between partially active and inactive forms of opsin, and the model provides an understanding of the structural requirements for opsin activation and an interpretation of the observed activities of natural and experimental opsin mutants.
Model of Abnormal Chromophore-Protein Interaction for Е181К Rhodopsin Mutation: Computer Molecular Dynamics Study
TLDR
The possible correlation between retinitis pigmentosa pathogenesis and the structural and functional properties of the rhodopsin protein is discussed and a stable covalent linkage of 11-cis-retinal with the protein part (viz. opsin) of the Rhodopin molecule will not form is suggested.
Pharmacological Chaperone-mediated in Vivo Folding and Stabilization of the P23H-opsin Mutant Associated with Autosomal Dominant Retinitis Pigmentosa*
Protein conformational disorders, which include certain types of retinitis pigmentosa, are a set of inherited human diseases in which mutant proteins are misfolded and often aggregated. Many opsin
G PROTEIN-COUPLED
TLDR
Several mutations have been described that constitutively activate the apoprotein opsin, and four of them have been shown to cause two different diseases of the retina, retinitis pigmentosa and congenital night blindness.
Defining the Retinoid Binding Site in the Rod Cyclic Nucleotide-gated Channel
TLDR
This work proposes that the cytoplasmic face of the channel contains a retinoid binding site that likely contains a hydrophobic region that allows the ion one ring and polyene tail to sit in an optimal position to promote interaction of the terminal functional group with residues ∼15 Å away from the ionone ring.
Structure and activation of the visual pigment rhodopsin.
TLDR
The emerging model of activation indicates that, rather than being unique, the visual receptors provide a basis for understanding the common structural and dynamic elements in the class A GPCRs.
...
...

References

SHOWING 1-10 OF 17 REFERENCES
Biochemistry
  • F. Young
  • Education
    The Indian Medical Gazette
  • 1955
The Department of Biochemistry is internationally recognized for its research and education and offers a world-class interdisciplinary research environment in a beautiful mountain setting. As part of
Nature Genetics
  • Nature
  • 1991
Proc. Natl
  • Proc. Natl
  • 1987
Biochemistry Nature
  • Biochemistry Nature
  • 1967
Biochemistry J. Biol. Chem. Science Science Chem. Soc. Chem. Cold Spring Harbor Laboratory Cold Spring Harbor, NY M., and Motto, M. G. J. Am. Chem. Soc. Chem. Pharm. Bull. Genomics
  • Biochemistry J. Biol. Chem. Science Science Chem. Soc. Chem. Cold Spring Harbor Laboratory Cold Spring Harbor, NY M., and Motto, M. G. J. Am. Chem. Soc. Chem. Pharm. Bull. Genomics
  • 1979
J. Am. Chem. Soc. Acad. Sci. U. S. A
  • J. Am. Chem. Soc. Acad. Sci. U. S. A
J. Biol. Chem
  • J. Biol. Chem
  • 1982
Eur: J. Biochem
  • Eur: J. Biochem
  • 1990
Angew. Chem. Int. Ed. Engl
  • Angew. Chem. Int. Ed. Engl
  • 1990
Biochem. J
  • Biochem. J
  • 1955
...
...